Purpose
To describe outcomes of patients with Terrien marginal degeneration.
Design
Retrospective case series.
Methods
Database review of 25 patients (43 eyes) seen over 10 years (2004–2013) at Toronto Western Hospital cornea clinic. Outcome measures included demographics, location of disease, topographic astigmatism, visual acuity, coexisting ocular disease, and surgical management.
Results
Mean age at presentation was 44 years (range, 20–82 years) and 54% were male. Eighteen patients (72%) had bilateral disease. Mean follow-up was 30.3 months. Mean topographic astigmatism was 4.02 diopters (D) at 5 degrees. Mean change in astigmatism 1 year from baseline was 0.75 D; at 2 years was 1.22 D; and at 3 years was 1.68 D. Mean best spectacle-corrected visual acuity (BSCVA) at presentation was 20/46 and 20/48 at last follow-up. Eyes requiring surgery (23.3%) had mean BSCVA of 20/81 at presentation and 20/106 after surgery. Five eyes perforated: 4 spontaneously, and 1 from trauma. Three eyes (6.9%) presented with pseudopterygium. Two eyes (4.7%) had intracorneal cysts. Fourteen patients (56%) presented with ocular surface inflammation.
Conclusions
Terrien marginal degeneration is a slow-progressing, bilateral but asymmetric degeneration of the peripheral cornea. Men over 40 are more commonly affected. Stromal thinning, vascularization, lipid deposition, and against-the-rule astigmatism are classic signs. Though typically noninflammatory, a variant form characterized by prominent inflammation exists. Surgery (lamellar graft) can preserve corneal integrity and is indicated when conventional options fail to maintain vision or if perforation is imminent. Perforations are rare but can result in significant vision loss.
Terrien marginal degeneration was first described by Terrien in 1990 as a bilateral, marginal ectasia of the cornea. This not-uncommon condition is now characterized as a slow-progressing, noninflammatory degeneration, initially presenting in the superonasal cornea. Though any age can be affected, literature suggests it appears primarily above the age of 40 and more commonly in men. Disease progression is classically slow, taking several years to develop. Patients are usually asymptomatic until continued thinning results in increased astigmatism and subsequent diminution of visual acuity. Perforations, either spontaneous or with minor trauma, are a serious consequence, but they are rare, with only a handful of reported cases.
Clinical hallmarks of Terrien marginal degeneration include ectasia and furrowing of the peripheral cornea with associated lipid deposition, as well as vascularization. Initial findings present as fine, white-yellow, punctate, stromal opacifications that appear similar to arcus senilis. Subsequent stromal thinning is heralded by the formation of a circumferential, gutter-like cavitation parallel to the limbus. In later stages, lipid deposition, visible as a solid white line, develops along the anterior edge ( Figure 1 ). This leading edge is steeply sloped, in contrast to the gradual slope of the posterior lip. Vascularization stems radially from the limbus and is located within the anterior stroma. An area of clear cornea can often be visualized between the leading edge of the gutter and the limbus. Pseudopterygia, at positions other than 3 o’clock and 9 o’clock, grow obliquely onto the cornea in approximately 20% of Terrien cases ( Figure 2 ). These pseudopterygia are thought to be characteristic of this condition and may occur in the earlier stages of disease, before marked thinning. Terrien degeneration typically presents bilaterally but can be very asymmetric between the 2 eyes. The superior cornea is primarily affected, but as the disease progresses, inferior cornea can also be involved.
The majority of patients with Terrien marginal degeneration lack signs and symptoms of inflammation. However, a variant form of the disease with prominent inflammatory findings has been identified by a number of investigators. Histopathologic examinations reveal an intact epithelium throughout the course of the disease, despite degeneration of the basal epithelial cells, and an abnormal appearance to the basement membrane. The Bowman layer and anterior stromal lamella are lost and replaced by vascularized connective tissue. Histiocytes that line the blood vessels have evidence of increased lysosomal activity and collagen deposition, consistent with a degenerative etiology. The Descemet membrane and endothelium are typically intact, though a number of reports have observed spontaneous ruptures in these layers, resulting in intralamellar dissection and intracorneal cysts ( Figure 3 ).
Although the clinical and histopathologic manifestations of Terrien degeneration are well documented, the literature on this condition is relatively sparse, and the exact etiology of the condition remains obscure. Herein we present a larger, retrospective study describing the clinical characteristics and outcomes of patients diagnosed with the condition in a tertiary corneal clinic at the Toronto Western Hospital from 2004 to 2013. The purpose of the study is, in part, to confirm reported findings with a larger, more robust population, and to draw on any new conclusions that may help the practicing ophthalmologist understand this disease better.
Methods
This retrospective observational case series was approved by the Research Ethics Board of the University Health Network (Approval #14-7486-C). This study was conducted in compliance with the tenets of the Declaration of Helsinki. A database search of patients seen over a 10-year period (2004–2013) with a diagnosis of Terrien marginal degeneration was conducted at a specialty cornea clinic at the Toronto Western Hospital, Toronto, Ontario, Canada. The charts of 43 eyes of 25 patients were reviewed retrospectively. Patients were excluded if they did not fit the diagnostic criteria of Terrien marginal degeneration, defined primarily by evidence of peripheral corneal thinning, superficial vascularization, and lipid deposition ( Figure 1 ). Patient demographics and clinical characteristics including location and laterality, visual acuity, topographic astigmatism, coexisting ocular disease, and need for surgical treatment were analyzed.
Results
The average age at diagnosis in this cohort of patients was 44 years (standard deviation [SD], 18 years; range, 20–82 years). Men were slightly more affected than women (54%, 14/25). Eighteen patients (72%) presented with bilateral involvement. Mean follow-up was 30.3 months (SD, 35.3 months; range, 0–114 months).
Twenty-eight eyes (65%) had either a superior or superior-nasal pattern of disease on initial presentation. The other 15 eyes (35%) presented initially with 360 degrees or >180 degrees of involvement. Topographic analysis was available in 29 eyes of 16 patients. Mean astigmatism at presentation was 4.02 diopters (D) at 5 degrees (SD, 3.49 D; range, 0.22–20.68 D). Data on change in topographic astigmatism were available in 1-year, 2-year, and 3-year intervals for 11 eyes, 7 eyes, and 6 eyes, respectively. In our cohort, astigmatic power increased by a mean of 0.75 D (SD, 1.09; range, −0.04 to 2.98 D) at 1 year, 1.22 D (SD, 3.02; range, −0.78 to 6.86 D) at 2 years from baseline, and 1.68 D (SD, 3.16; range, −0.64 to 7.64 D) by the third year of follow-up.
Surgery was required in 10 of 43 eyes (23.3%), and a corneal lamellar graft was performed in 7 of these cases. Corneal perforation occurred in 5 eyes (11.6%, 5/43), 4 of which perforated spontaneously, and 1 owing to trauma. Individual and ocular details for patients requiring surgery are shown in the Table .
Case | Patient | Sex | Age | Eye | Ocular Comorbidities | Symptoms | Topographic Astigmatism | BSCVA Pre-op | BSCVA Post-op | Other Findings | Perforation | Surgical Treatments | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Decreased Vision | Redness/Soreness | Cyl (D) | Axis | |||||||||||
1 | 1 | M | 34 | OD | Cataract | + | 6.67 | 175 | 20/100 | 20/70 | Ghost vessels | LK, P&IOL | ||
2 | 2 | M | 50 | OD | Blepharitis, cataract | + | 2.57 | 41 | 20/25 | 20/25 | Pseudopterygium | SK, AMG | ||
3 | 2 | M | 50 | OS | Blepharitis, cataract | + | 10.82 | 32 | 20/25 | 20/200 | Pseudopterygium | + | LK, P&IOL, AMG | |
4 | 3 | M | 58 | OD | Blepharitis, cataract | + | + | 5.59 | 6 | 20/40 | 20/200 | Rosacea | + | Rupture repair, aphakia + IOL, iridoplasty |
5 | 3 | M | 58 | OS | Blepharitis, cataract | + | + | 8.59 | 148 | 20/50 | 20/70 | Rosacea | LK | |
6 | 4 | M | 47 | OD | Glaucoma | + | N/A | N/A | 20/400 | 20/400 | + | PKP, AMG | ||
7 | 5 | F | 67 | OD | Scleral thinning | + | 13.4 | 8 | 20/400 | 20/80 | LK | |||
8 | 6 | F | 45 | OD | Blepharitis | + | + | 20.68 | 93 | 20/400 | 20/80 | LK, P&IOL | ||
9 | 7 | F | 20 | OS | Blepharitis | + | 8.47 | 139 | 20/50 | 20/200 | Intracorneal cyst | + | LK | |
10 | 8 | M | 20 | OS | 1.67 | 59 | 20/25 | 20/70 | + | LK |